|
|
|
|
| LEADER |
02824nam a2200553 4500 |
| 001 |
ocn983779365 |
| 003 |
OCoLC |
| 005 |
20180501122035.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
170424s2017 mau ob 001 0 eng d |
| 040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d N$T
|d YDX
|d IDEBK
|d OCLCF
|d OCLCQ
|d OPELS
|d UAB
|d GZM
|d UPM
|d D6H
|d GrThAP
|
| 019 |
|
|
|a 982859908
|
| 020 |
|
|
|a 9780128124086
|q (electronic bk.)
|
| 020 |
|
|
|a 0128124083
|q (electronic bk.)
|
| 020 |
|
|
|a 9780128124079
|q (print)
|
| 020 |
|
|
|a 0128124075
|
| 035 |
|
|
|a (OCoLC)983779365
|z (OCoLC)982859908
|
| 050 |
|
4 |
|a QR181
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.07/9
|2 23
|
| 049 |
|
|
|a TEFA
|
| 245 |
0 |
0 |
|a Advances in immunology.
|n Volume 134 /
|c edited by Frederick W. Alt.
|
| 264 |
|
1 |
|a Cambridge, MA :
|b Academic Press is an imprint of Elsevier,
|c 2017.
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in immunology ;
|v volume 134
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect, viewed April 24, 2017).
|
| 588 |
0 |
|
|a Print version record.
|
| 520 |
|
|
|a Advances in Immunology, Volume 134, the latest in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology. Articles address the wide range of topics that comprise immunology, with this latest update including chapters on GPCR Biology, the Role of Caveolin-1 in BCR and TCR Receptors, New Developments in the Chemokine Field, and The Complement System in Developmental Neurobiology and Neurodegeneration. Readers will find comprehensive information on molecular and cellular activation mechanisms, phylogeny and molecular evolution and clinical modalities. Edited and authored by the foremost scientists in the field, each volume provides up-to-date information and directions for the future.
|
| 650 |
|
0 |
|a Immunology.
|
| 650 |
|
7 |
|a HEALTH & FITNESS / Diseases / General
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Clinical Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Diseases
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Evidence-Based Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Internal Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a Immunology.
|2 fast
|0 (OCoLC)fst00968006
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Alt, Frederick W.,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|z 0128124075
|z 9780128124079
|w (OCoLC)957680867
|
| 830 |
|
0 |
|a Advances in immunology ;
|v v. 134.
|
| 856 |
4 |
0 |
|u https://www.sciencedirect.com/science/bookseries/00652776/134
|z Full Text via HEAL-Link
|
